UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046917
Receipt number R000053528
Scientific Title The mood-enhancing effect of viewing images of the natural environment in major depression and anxiety disorders
Date of disclosure of the study information 2022/03/01
Last modified on 2024/07/08 14:01:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The mood-enhancing effect of viewing images of the natural environment in major depression and anxiety disorders

Acronym

The mood-enhancing effect of viewing images of the natural environment in major depression and anxiety disorders

Scientific Title

The mood-enhancing effect of viewing images of the natural environment in major depression and anxiety disorders

Scientific Title:Acronym

The mood-enhancing effect of viewing images of the natural environment in major depression and anxiety disorders

Region

Japan


Condition

Condition

depressive disorder, anxiety disorder

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of viewing images of natural environment on mood and brain activations in patients with depression and anxiety disorders. Furthermore, to investigate the moderating effect of symptoms of depression and anxiety, cognitive functions on the effect of viewing images of natural environment.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

1) Mood immediate after intervention evaluated by visual analog scale
2) Brain activations during intervention as evaluated by NIRS

Key secondary outcomes

1) Heart rate and heart rate variability during intervention
2) The association between mood and brain activations
3) The influence of personal characteristics such as mental health states and cognitive functions on the effect of viewing the image of natural environment (eg, the more severe the depression, the greater the effect of viewing images)
4) Relationships among other personal characteristics


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Images of green natural environments such as forest, countryside, etc. are presented on a 27-inch high-resolution display for 3 minutes.

Interventions/Control_2

Images of artificial environments such as cities are presented on a 27-inch high-resolution display for 3 minutes.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

1) Being diagnosed as having a depressive disorder or anxiety disorder based on DSM-5.
2) Age is 20 to 65 at the time of obtaining consent.
3) No color vision deficiency and having visual acuity (corrected visual acuity is also possible) of 0.6 or more, or no effect of vision problems on daily activities, by self-declaration (colored glasses are not allowed).
4) Right-handed.
5) A person who, after receiving a sufficient explanation before participating in this research, has a sufficient understanding and provided informed consent.

Key exclusion criteria

1) Having strong suicide ideation.
2) Those who are judged to be unsuitable as research subjects by the researcher in charge of the experimental sessions (for example, those who cannot conduct the experiments smoothly due to physical illness).

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Shin
Middle name
Last name Nakagawa

Organization

Yamaguchi University Graduate School of Medicine

Division name

Division of Neuropsychiatry, Department of Neuroscience

Zip code

7558505

Address

Minamikogushi 1-1-1, Ube, Yamaguchi, Japan

TEL

0836222254

Email

brain@yamaguchi-u.ac.jp


Public contact

Name of contact person

1st name Chong
Middle name
Last name Chen

Organization

Yamaguchi University Graduate School of Medicine

Division name

Division of Neuropsychiatry, Department of Neuroscience

Zip code

755-8505

Address

Minamikogushi 1-1-1, Ube, Yamaguchi, Japan

TEL

0836222254

Homepage URL


Email

brain@yamaguchi-u.ac.jp


Sponsor or person

Institute

Division of Neuropsychiatry, Department of Neuroscience, Yamaguchi University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yamaguchi University Hospital Institutional Review Board

Address

Minamikogushi 1-1-1, Ube, Yamaguchi, Japan

Tel

0836-22-2428

Email

clin_res@yamaguchi-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

山口大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2021 Year 12 Month 10 Day

Date of IRB

2022 Year 01 Month 26 Day

Anticipated trial start date

2022 Year 03 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2025 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2022 Year 02 Month 15 Day

Last modified on

2024 Year 07 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053528